A New Route to Substituted Pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones and Facile Extension to 5,7(6H,8H) Isomers
Pyrimido[5,4,e]-1,2,4-triazine-5,7-diones such as the natural products toxoflavin (1) and fervenulin (2) (Figure 1 ) exhibit antibiotic and other useful pharmacological activity, motivating interest in their exploration since the early 1960s.
1 While a variety of analogues have been synthesized and evaluated within both templates, one subclass conspicuously absent is that with aryl substituents at the N 1 -position, 3, whereas analogues with similar substituents at N 8 , 4, have been reported. 2 We recently have reported on a novel synthesis of compounds related to 1, including hitherto inaccessible N 1 -phenyl analogues 3. 3 In this paper, we report on the further application of this synthesis to a variety of N 1 -alkyl and N 1 -aryl compounds, and an efficient process for extending this synthesis to the generation of compounds within the isomeric fervenulin series.
The strategy and range of analogues synthesized within the pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-dione (toxoflavine) series is shown in Table 1 . First, monosubstituted hydrazines 5, either as the free base or hydrochloride salt, were condensed under reflux with aromatic aldehydes 6 in ethanol or tetrahydrofuran to form hydrazones 7, which usually precipitated out of solution upon cooling. The resulting hydrazones 7 were then treated with 6-chloro-3-methyl-5-nitrouracil (8) , which had been formed by nitration of commercially available 6-chloro-3-methyluracil according to the published method. 4 The addition to 8 required catalysis with aluminum trichloride for those hydrazones formed from arylhydrazines. The resultant 6-(2-arylidene-1-substituted-hydrazinyl)-3-methyl-5-nitrouracils 9 were then cyclized to 3-(4-aryl)-6-methyl-1-substituted-pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones 10 upon treatment with zinc dust (4 equiv) and ammonium chloride (2 equiv) while exposed to the air and with vigorous stirring in refluxing 50% aqueous ethanol. The N 1 -substituted pyrimidotriazinediones were then isolated cleanly, usually in >60% yield, by washing with aqueous 1 M hydrochloric acid. Other solvents and combinations thereof were tried for the zincmediated cyclization, but the yields were considerably diminished. Further, additional standard methods were evaluated to reduce the nitro group and promote cyclization. These included standard hydrogenation over palladium on carbon, transfer hydrogenation (Pd/C, ammonium formate), tin in ethyl acetate, tin(II) chloride dihydrate in ethanol, iron in glacial acetic acid, and zinc/hydrochloric acid in ethanol, but none provided clean product. For Ar and R = aryl, the method was amenable to a variety of substituents on either ring (Table 1 , entries 1-8). Both electron-donating and electron-withdrawing substituents were tolerated on either component and there was variation in overall yield depending on the combination of moieties examined. However, the hydrazone formed from 2-pyridylhydrazine was unreactive, perhaps due to catalyst deactivation via complexation of the adjacent pyridyl nitrogen with aluminum trichloride. An attempt to conduct this reaction in the absence of catalyst and at higher temperatures led only to recovered hydrazone. In optimizing the reaction sequence, it was found that hydrazones 7, where R = aryl, did not need to be isolated in a separate step (Table 1 , Method A) and that yields of 9 were often improved by forming the hydrazone in situ. Hence, this became the preferred method. In the improved protocol (Table 1 , Method B), 6-chloro-3-methyl-5-nitrouracil (8) and aluminum trichloride were added after 1-2 hours of reaction time between the arylhydrazine 5 and arylaldehyde 6 in an appropriate solvent. After a solvent screen that included standard chlorinated solvents (no reaction) and acetonitrile (modest reaction), tetrahydrofuran was found to provide superior yields. In addition to arylhydrazines, the methodology was investigated for a variety of alkylhydrazines 5 (R = alkyl), and here the hydrazones 7 formed in situ were found to be sufficiently reactive with chlorouracil 8 that activation with aluminum trichloride was unnecessary. Table 1 (Method C; entries 9-13) summarizes reactions for successful alkylhydrazines. In addition to those shown, the hydrazones of methylhydrazine also reacted quickly and efficiently with 8;
however, in the subsequent cyclization of 9 to 10 with zinc and ammonium chloride, demethylation at N 1 was a significant side reaction. Varying the reaction time and temperature could minimize this, but it was never completely suppressed. Hence, for R = methyl, the preferred method of synthesis would be one of the standard methods commonly used to make N 1 -methylpyrimidotriazinediones, 5 but for most other R substituents, our new methodology is advantageous with regard to both synthesis time and efficiency. Moreover, for Methods B and C, the sequence of in situ formation of hydrazone 7 followed by condensation with chloronitrouracil 8 and subsequent cyclization to 10 can be carried out with yields comparable to or better than when 7 is isolated separately.
There are some shortcomings to this methodology, however. The reaction between hydrazones 7 and 6-chloro-3-methyl-5-nitrouracil (8) was the more general of the last two steps. An example where the desired Michael-type addition to 8 did not occur included the hydrazone of tertbutylhydrazine. For the cyclization of 9 to 10, reaction Table 2 . Hydrazone formation in situ and subsequent reaction with 8 without AlCl 3 catalysis (Method C).
conditions were robust for aryl and some alkyl substituents at the N 1 -position. However, problems were encountered for both benzyl and methyl (as described above) substituents. While N 1 -methylpyrimidotriazinediones could be isolated to some extent, despite the competing demethylation, no desired N 1 -benzylpyrimidotriazinediones 10 could be detected as debenzylation appeared to rapidly follow cyclization. A similar outcome was observed for R = (CH 2 ) 2 NEt 2 with N 1 -C bond cleavage likely occurring via an aziridinium intermediate.
The demethylation that occurred when R = Me in the formation of 10 could be used to advantage, however, when the goal was an N 8 -H pyrimidotriazinedione. While hydrazine itself could be used in the initial condensation with aldehydes 6 to form hydrazones 7 (R = H), subsequent reaction of these with chlorouracil 8 followed by reductive ring closure with zinc and ammonium chloride never provided clean N 1 (N 8 )-H pyrimidotriazinediones. Hence, methylhydrazine could be used as a surrogate to attain the same objective. Table 2 lists several examples where 3-aryl-substituted pyrimidotriazinediones were made in this two-pot three-step process. Here, slightly lower yields were obtained in the ring closure/demethylation step when there was an electron-donating substituent at the 4-position of the aryl substituent ( Table 2 , entries 6 and 7), whereas the highest yields were obtained with the strongly electron-withdrawing fluoro group at the same position ( Table 2 , entries 3 and 8). Both of these observations are consistent with the ease with which demethylation of N 1 -methylpyrimidotriazinediones occurred. This involves a likely mechanism of S N 2 nucleophilic attack of the N 1 -methyl group by solvent followed by C-N bond cleavage with the core pyrimidotriazinedione heterocycle serving as a leaving group.
The demethylated pyrimidotriazinediones could then be alkylated to produce a variety of novel N 8 -substituted pyrimidotriazinedione analogues, as shown in Table 3 . This reaction, which has been previously documented in the literature, 6 can be subjected to conditions that provide either N 1 -or N 8 -alkyl products or mixtures thereof. Our conditions, which involve the use of cesium carbonate as base, provide N8 products exclusively for a wide range of alkyl and alkaryl substituents. While yields are variable, these were not optimized except for 11i and 11j. )-unsubstituted congeners, which can be mildly and regioselectively functionalized at the N 8 -position with alkyl and alkaryl halides. We expect this chemistry to find wide application toward the discovery of novel pharmacological agents.
All starting materials were obtained from commercial suppliers and were used without further purification. THF was distilled prior to use over Na/benzophenone. Reactions were run under a blanket of N 2 unless specified otherwise. Glassware was oven-dried before use for reactions run under anhydrous conditions. Melting points were determined in open capillary tubes on a Laboratory Devices MelTemp apparatus and are uncorrected. The NMR spectra were recorded on a Bruker instrument at 500 MHz for 1 H, 125 MHz for 13 C, and 470 MHz for 19 F spectra. Mass spectra were recorded on a Micromass TofSpec-2E Matrix-Assisted, Laser-Desorption, Time-ofFlight mass spectrometer.
All known compounds had spectroscopic (NMR and MS) and physical properties identical to those given in the literature. There are preparative procedures in the literature for the synthesis of hydrazones 7a, 7 7b 8 and 7c 9 of Table 1 , (hydrazinyl)nitropyrimidinediones 9n, 10 9q 10 and 9s 10 of Table 2 , pyrimidinotriazines 10n, 10 10q 10 and 10s 10 of Table 2 , and alkylated pyrimidinotriazines 11a 11 and 11c 12 of Table 3 .
2-Substituted 1-(4-Arylidene)hydrazines 7; General Procedure for Method A
A mixture of aryl-or alkylhydrazine 5, arylaldehyde 6 (1.1 equiv), and abs EtOH (0.5-0.7 M) was heated at reflux for 90 min. The soln was left standing at r.t. for several hours and the formed precipitate was collected by filtration, rinsed thoroughly with EtOH, and dried. It was used directly in the next step. MS: m/z = 422.1 (M + Na).
1-(4-
6-(2-Arylidene-1-substituted-hydrazinyl)-3-methyl-5-nitropyrimidine-2,4(1H,3H)-diones 9 via In Situ Generation of Hydrazone 7; General Procedure for Methods B and C Method B: A mixture of aryl-or alkylhydrazine 5 and arylaldehyde 6 (1.1 equiv) was dissolved in anhyd THF (0.3 M) and the soln was heated at reflux for 1.5 h. The soln was cooled to r.t, and chlorouracil 8 (0.9 equiv) was added, followed by AlCl 3 (1.0 equiv). The mixture was returned to reflux for 4 h and then cooled on ice for several hours. The formed precipitate was collected by filtration, rinsed with THF and EtOH, and dried.
Method C: The same initial steps for Method B were followed, except that the catalyst was omitted. A precipitate began to form within 5-10 min after addition of 8. The mixture was heated for an additional 20-45 min. Further processing as per Method B provided product 9.
Pyrimidotriazinediones 10; General Procedure MS: m/z = 284.1 (M -H).
8-Alkylpyrimido[5,4-e]-1,2,4-triazine-5,7(6H,8H)-diones 11;
General Procedure A mixture of 3-arylpyrimidotriazinedione 10, Cs 2 CO 3 (1.5 equiv), alkyl halide (1.2 equiv), and acetone (0.1 M) was stirred at r.t. overnight (bromides) or heated to 50 °C in a sealed vessel overnight (chlorides). The mixture was diluted with H 2 O, and refrigerated for 3-4 h. The resulting precipitate was collected, washed with H 2 O, and dried to provide 11. Fluorobenzyl)-6-methyl-3-phenylpyrimido[5,4-e]-1,2,4 
8-(3-

